4-68929882-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024743.4(UGT2A3):c.1515G>T(p.Leu505Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,610,382 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024743.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UGT2A3 | NM_024743.4 | c.1515G>T | p.Leu505Phe | missense_variant | 6/6 | ENST00000251566.9 | |
UGT2A3 | XM_011532247.3 | c.1533G>T | p.Leu511Phe | missense_variant | 6/6 | ||
UGT2A3 | XM_047416177.1 | c.648G>T | p.Leu216Phe | missense_variant | 6/6 | ||
UGT2A3 | NR_024010.2 | n.1656G>T | non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UGT2A3 | ENST00000251566.9 | c.1515G>T | p.Leu505Phe | missense_variant | 6/6 | 1 | NM_024743.4 | P1 | |
UGT2A3 | ENST00000503012.1 | c.*691G>T | 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151976Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248118Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134008
GnomAD4 exome AF: 0.0000247 AC: 36AN: 1458406Hom.: 0 Cov.: 30 AF XY: 0.0000290 AC XY: 21AN XY: 725362
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151976Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74222
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.1515G>T (p.L505F) alteration is located in exon 6 (coding exon 6) of the UGT2A3 gene. This alteration results from a G to T substitution at nucleotide position 1515, causing the leucine (L) at amino acid position 505 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at